NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION

Budget/Appropriations BUD

FY 2018 Appropriations for the Dept. of Health and Human Services, Food and Drug Administration, and Dept. of Veterans Affairs.

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Comments on End Stage Renal Disease program Prospective Payment System Transitional Drug Add-on Payment Comments on Medicare Model Guidelines 7.0 Comments on Incident ESRD Clinical Episode Payment Model

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE; Natl Institutes of Health (NIH)

Health Issues HCR

Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Comments on establishment of FDA Office of Patient Affairs

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 1270 (115th)